Kubota Pharmaceutical Holdings Co., Ltd.

KBBTFOTCHealthcare

$0.96

+$0.00(+0.00%)

Market Cap$24097728

P/E Ratio—

52W High$2.81

52W Low$0.96

Avg Volume3

Open$0.96

Beta1.18

Overview

Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

KBBTF · earnings · updated Jun 10, 2026

Latest Earnings

Q1 FY2023Report Date: Feb 14, 2023

EPS Actual

-$6.23

Revenue

—

Fiscal Period

Q1 FY2023

FY ends December

Report Date

Feb 14, 2023

After Market Close

KBBTF reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Next earnings date not yet announced.

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q1 FY2023	Feb 14, 2023	—	-$6.23	—	—	—	—
— Q4 FY2022	Nov 11, 2022	—	-$9.44	—	—	—	—
— Q3 FY2022	Aug 12, 2022	—	-$11.73	—	—	—	—
— Q2 FY2022	May 13, 2022	—	-$14.30	—	—	—	—
— Q4 FY2021	Nov 12, 2021	—	-$12.65	—	—	—	—
— Q3 FY2021	Aug 12, 2021	—	-$14.39	—	—	—	—
— Q2 FY2021	May 13, 2021	—	-$15.48	—	—	—	—
— Q1 FY2021	Feb 12, 2021	—	-$12.84	—	—	—	—

Q1 FY2023

Feb 14, 2023

EPS Actual

-$6.23

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2022

Nov 11, 2022

EPS Actual

-$9.44

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2022

Aug 12, 2022

EPS Actual

-$11.73

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2022

May 13, 2022

EPS Actual

-$14.30

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2021

Nov 12, 2021

EPS Actual

-$12.65

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2021

Aug 12, 2021

EPS Actual

-$14.39

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2021

May 13, 2021

EPS Actual

-$15.48

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2021

Feb 12, 2021

EPS Actual

-$12.84

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for KBBTF.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q1 FY2023	Feb 14, 2023	—	$0.96	—	—
— Q4 FY2022	Nov 11, 2022	—	$1.85	$0.95	-48.65%
— Q3 FY2022	Aug 12, 2022	—	$1.85	$0.95	-48.65%
— Q2 FY2022	May 13, 2022	—	$1.80	$1.95	+8.33%
— Q4 FY2021	Nov 12, 2021	—	$1.80	$1.80	+0.00%
— Q3 FY2021	Aug 12, 2021	—	$2.04	$2.04	+0.00%
— Q2 FY2021	May 13, 2021	—	$2.42	$2.42	+0.00%
— Q1 FY2021	Feb 12, 2021	—	$2.66	$2.66	+0.00%

Q1 FY2023—

Report Date

Feb 14, 2023

EPS Beat/Miss

—

Price Before

$0.96

Price After

—

Q4 FY2022-48.65%

Report Date

Nov 11, 2022

EPS Beat/Miss

—

Price Before

$1.85

Price After

$0.95

Q3 FY2022-48.65%

Report Date

Aug 12, 2022

EPS Beat/Miss

—

Price Before

$1.85

Price After

$0.95

Q2 FY2022+8.33%

Report Date

May 13, 2022

EPS Beat/Miss

—

Price Before

$1.80

Price After

$1.95

Q4 FY2021+0.00%

Report Date

Nov 12, 2021

EPS Beat/Miss

—

Price Before

$1.80

Price After

$1.80

Q3 FY2021+0.00%

Report Date

Aug 12, 2021

EPS Beat/Miss

—

Price Before

$2.04

Price After

$2.04

Q2 FY2021+0.00%

Report Date

May 13, 2021

EPS Beat/Miss

—

Price Before

$2.42

Price After

$2.42

Q1 FY2021+0.00%

Report Date

Feb 12, 2021

EPS Beat/Miss

—

Price Before

$2.66

Price After

$2.66

Beat Rate0 / 8 quarters

Largest Move-48.65% (Q4 FY2022)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) most recently reported earnings on February 14, 2023 for Q1 FY2023, posting EPS of $-6.23 (in line with the analyst consensus of —).

Each quarter, investors track KBBTF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. KBBTF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

KBBTF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

KBBTF earnings · 4 questions

Kubota Pharmaceutical Holdings Co., Ltd.'s next earnings report is expected around TBD. KBBTF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; KBBTF historically reports after market close (AMC).

KBBTF earnings datewhen is KBBTF earningsKBBTF next earnings datewhen does KBBTF report earningsKBBTF earnings calendar

▸ Source: FMP · Kubota Pharmaceutical Holdings Co., Ltd. SEC filings · US GAAP · Kubota Pharmaceutical Holdings Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026